Recommendations of the Spanish Brachytherapy Group of SEOR for HDR endoluminal treatments. Part 1: Oesophagus

• Á. Rovirosa ^[7] ; J. Anchuelo ^[5] ; V. Crispin ^[1] ; C. Gutiérrez ^[2] ; A. Herreros ^[7] ; I. Herruzo ^[4] ; J. C. Menéndez ^[5] ; P. Pino ^[2] ; A. Polo ^[3] ; S. Rodríguez ^[6]
  1. [1] Instituto Valenciano de Oncologia

     Instituto Valenciano de Oncologia

     Valencia, España

     
  2. [2] Institute Catalá Oncología

     Institute Catalá Oncología

     Barcelona, España

     
  3. [3] Hospital Ramón y Cajal

     Hospital Ramón y Cajal

     Madrid, España

     
  4. [4] Hospital Carlos Haya
  5. [5] Hospital Marqués de Valdecilla
  6. [6] Hospital Clínica Benidorm
  7. [7] Hospital Clínic I Universitari

  Mostrar afiliaciones +
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 17, Nº. 8 (August), 2015, págs. 581-589
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • The endoesophageal brachytherapy technique provides good results in the treatment of oesophageal cancer, when indicated. In a consensus meeting, the Spanish Brachytherapy Group of SEOR and the Spanish Society of Medical Physics (SEFM) agreed on the indications, dose, fractionation schedule, prescription and reporting to be performed in endoesophageal brachytherapy. The results of this consensus are presented here as recommendations for medical practice.